Benefit-Hematotoxicity Stratification in Patients with Triple-Negative Breast Cancer Receiving Platinum-Based Neoadjuvant Therapy: A Multitask Deep Learning Study.

Sun H, Zhou X, Liang J, Shi Y, Deng B, Guo Z, Su T, Guo B, Zhong L

Open source

DOI
10.3390/cancers18172842
Published
2026 Sep 2
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18172842,
  title = {Benefit-Hematotoxicity Stratification in Patients with Triple-Negative Breast Cancer Receiving Platinum-Based Neoadjuvant Therapy: A Multitask Deep Learning Study.},
  author = {Sun H and Zhou X and Liang J and Shi Y and Deng B and Guo Z and Su T and Guo B and Zhong L},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18172842},
  url = {https://doi.org/10.3390/cancers18172842}
}

RIS

TY  - JOUR
TI  - Benefit-Hematotoxicity Stratification in Patients with Triple-Negative Breast Cancer Receiving Platinum-Based Neoadjuvant Therapy: A Multitask Deep Learning Study.
AU  - Sun H
AU  - Zhou X
AU  - Liang J
AU  - Shi Y
AU  - Deng B
AU  - Guo Z
AU  - Su T
AU  - Guo B
AU  - Zhong L
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18172842
UR  - https://doi.org/10.3390/cancers18172842
ER  - 

APA

H, S., X, Z., J, L., Y, S., B, D., Z, G., T, S., B, G., & L, Z. (2026). Benefit-Hematotoxicity Stratification in Patients with Triple-Negative Breast Cancer Receiving Platinum-Based Neoadjuvant Therapy: A Multitask Deep Learning Study.. Cancers. https://doi.org/10.3390/cancers18172842

Source records